University of Wisconsin, Madison: Neoplasms trials
The registry lists 13 Neoplasms studies with University of Wisconsin, Madison as lead sponsor. 2 are open to participants now and 5 have results posted.
Phase 1 6Phase 2 4Phase 4 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care DeliveryRecruitingNCT07532083
- Evaluating the Communication Between Patients and Providers in Cancer ClinicsRecruitingNCT06985953Not applicable
- Tobacco Treatment Comparison for Cancer CareCompletedNCT06218823Phase 4Results posted
- Split-Dose R-CHOP for Older Adults With DLBCLActive, not recruitingNCT03943901Phase 2Results posted
- Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFRTerminatedNCT02720185Phase 2Results posted
- Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate CancerCompletedNCT02499835Phase 1/2Results posted
- CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary CarcinomaCompletedNCT00634751Phase 1/2Results posted
- Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETsTerminatedNCT02943733Phase 1
- Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose AxitinibCompletedNCT01540526Phase 1
- Pharmacodynamic Study of Axitinib in Patients With Advanced Solid MalignanciesCompletedNCT00859118Phase 1
- Thoracic OncoGeriatric Assessment (TOGA) TrialsCompletedNCT00591981
- Validation of a Novel Thoracic Neoplasm Radiotherapy Image Guidance Technique: A Pilot StudyWithdrawnNCT00585819Not applicable
- PS-341 and Doxorubicin in Treating Patients With Advanced Solid TumorsCompletedNCT00023855Phase 1